OTHER NEWS - Nov. 18, 1994
- Share via
From Times Staff and Wire Reports
A federal advisory committee recommended against Food and Drug Administration approval of the Proctor & Gamble drug Didrocal for treating post-menopausal osteoporosis. . . . First Chicago Corp. disclosed that it lost $7.2 million after rescuing several mutual funds with investments in risky derivatives securities that went sour.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.